Advances in CRISPR gene editing technology are moving closer to clinical applications. Researchers are developing more precise tools to target specific genes, with applications ranging from treating genetic disorders to modifying cells for immunotherapy. One notable trend is the use of CRISPR in cell-based therapies, where a patient’s own cells are engineered outside the body and then reintroduced to fight diseases like certain cancers. Additionally, progress is being made in delivering the editing machinery more safely and efficiently to target tissues. These developments hold promise for personalized medicine but also raise important ethical and safety considerations that will need careful regulation as the technology matures.
About the Author
